Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Comparison6 min read

HealthRx Alternatives 2026: Six Options, Priced

Six HealthRx alternatives if $125/month after a $39 first month is too high or you want a track record - from embody's $49 flat to welludr's $41.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • Shoppers leave HealthRx for three reasons: $125/month is above several monthly rivals, the newer brand lacks a track record, or tirzepatide at $199 is beatable.
  • Lower monthly price, no commitment: embody is $49/month flat with cancel-anytime terms and a refund if not approved ($76 a month below HealthRx's $125); altRx ($89, pause anytime) adds Buy Now, Pay Later.
  • Track record: welludr pairs $41/month with over one million patients and a weight-loss warranty; Medvi ($99 promo) brings video visits and a dietician on every plan.
  • Tirzepatide: welludr $71, embody $99, altRx $149 and Medvi $166 promo all beat HealthRx's $199 - monthly gaps of $33-$128.

Why people balk - and what each objection points to

The short answerShoppers leave HealthRx because $125 a month is above several monthly rivals, the newer brand lacks a track record, or tirzepatide at $199 is beatable. For a lower monthly price with no commitment, embody is $49 a month flat with cancel-anytime terms and altRx ($89, pause anytime) adds Buy Now, Pay Later; for a track record, welludr pairs $41 a month with a weight-loss warranty and Medvi brings video visits and a dietician on every plan; for tirzepatide, welludr $71, embody $99, altRx $149 and Medvi $166 promotional all beat $199.

HealthRx's program itself audits well (LegitScript-certified, clinician-gated, overnight cold-chain - the case is in our legitimacy investigation). When shoppers walk away, it's for one of three reasons: the $125 monthly price is above several rivals, the newer brand hasn't earned trust yet, or tirzepatide at $199 is beatable. Each objection has a precise best answer - not a generic list.

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review
3
TrimRx logo

Very Good

8.9out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA
  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Telehealth GLP-1 program built around custom dosing and unlimited provider check-ins - compounded semaglutide $149/month, the same at every dose, and tirzepatide $259/month.

Read full TrimRx review

Objection: "The monthly price is too high" → embody, then altRx

embody is the anti-commitment pick: $49/month flat, cancel anytime, and your total exposure on month one is $49. It keeps most of what makes HealthRx attractive (LegitScript certification, 503A pharmacies, free expedited delivery with no timeline guaranteed, vs overnight) and adds a partial refund (unused portion less services rendered) if a provider doesn't approve you. It's also cheaper per month: $49 vs $125. altRx ($89/month, pause anytime) is the runner-up with a twist - Buy Now, Pay Later, which suits anyone who wants to spread the cost.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

Objection: "newer brand, no track record" → welludr or Medvi

Track record shopping has two ends. welludr pairs budget pricing ($41/month, 12-month lock billed monthly) with scale: over one million patients and a weight-loss warranty. Medvi (currently $99/month promotional, all-inclusive) brings video visits and a dietician on every plan. Both are established programs - we ran the direct matchup in HealthRx vs Medvi.

Objection: "tirzepatide pricing" → four cheaper doors

HealthRx's tirzepatide is $199 a month after a $39 first month; four providers beat it outright: welludr at $71, embody at $99, altRx at $149 and Medvi at $166 promotional. Monthly gaps run $33-$128.

AlternativeSemaglutideUpfront exposureBeats HealthRx on
embody$49/mo$49No commitment, refund policy, monthly price
welludr$41/moOne monthPrice + million-patient scale
altRx$89/moOne month (BNPL)Flexibility + brand-name shelf
DirectMeds$249/mo (sublingual)One monthNeedle-free format
Medvi$99/mo promoOne monthSupport + video visits
SHED$199/moOne monthCoaching + money-back guarantee

And the counter-case for staying: if overnight delivery and a $39 first month matter to you, none of the objections apply - HealthRx at $125 with the best logistics in the ranking is exactly what it claims to be.

→ Sixty seconds to a personalized answer: take the matching quiz

This article is general information, not medical advice. Prices as listed at the time of writing.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)